Security key
76155X100
Revolution Medicines, Inc. - COMMON STOCK (RVMD)
CUSIP: 76155X100
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 191,051,347
- Total 13F value
- $6,776,444,446
- Share change
- -2,259,360
- Put/Call ratio
- 361%
- SEC-reported price per share
- $35.36
- Number of holders
- 281
- Value change
- -$111,943,197
- Number of buys
- 142
- Number of sells
- 129
- Shares outstanding
- 213,918,097
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
281
Top holders
10
RVMD full security history
Ownership snapshot
Full 13F holder table
Revolution Medicines, Inc. SEC filings
Revolution Medicines, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of RVMD - Revolution Medicines, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Third Rock Ventures III, ...
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
31 Dec 2024
3/4/5
13F
Highest disclosed value: $747,798,942
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC has the largest disclosed position value at $747.8M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value
Top 5
Third Rock Ventures III, L.P.
$137.81M
Third Rock Ventures II, L.P.
$349K
VANGUARD GROUP INC
$747.8M
BlackRock, Inc.
$643.83M
FARALLON CAPITAL MANAGEMENT, L.L.C.
$579.52M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Third Rock Ventures III, L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$137,811,510
5,104,130 shares
|
— | 08 Jun 2022 |
| Third Rock Ventures II, L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$348,975
12,925 shares
|
— | 03 Jun 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$747,798,942
17,096,455 shares
|
— | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
—
denominator unverified
|
$643,833,029
14,719,548 shares
|
— | 31 Dec 2024 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. |
13F
Company
|
—
mixed-class rows
|
$579,517,194
13,368,777 shares
mixed-class rows
|
— | 31 Dec 2024 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
—
denominator unverified
|
$473,340,765
10,821,691 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
281
Shares
191,051,347
Rows available
281
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
281
Q1 2025 holders
281
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|